Atai Life Sciences N.V. (ATAI)
NASDAQ: ATAI · Real-Time Price · USD
2.240
+0.130 (6.16%)
At close: Jun 16, 2025, 4:00 PM
2.230
-0.010 (-0.45%)
Pre-market: Jun 17, 2025, 8:12 AM EDT
Atai Life Sciences Market Cap
Atai Life Sciences has a market cap or net worth of $449.69 million as of June 17, 2025. Its market cap has increased by 59.89% in one year.
Market Cap
449.69M
Enterprise Value
380.45M
1-Year Change
59.89%
Ranking
Category
Stock Price
$2.24
Market Cap Chart
Since the IPO on June 18, 2021, Atai Life Sciences's market cap has decreased from $2.29B to $449.69M, a decrease of -80.35%. That is a compound annual growth rate of -33.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 16, 2025 | 449.69M | 101.49% |
| Dec 31, 2024 | 223.18M | -4.66% |
| Dec 29, 2023 | 234.07M | -46.95% |
| Dec 30, 2022 | 441.23M | -63.92% |
| Dec 31, 2021 | 1.22B | -46.56% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 724.99B |
| Johnson & Johnson | 373.47B |
| Novo Nordisk | 343.59B |
| AbbVie | 337.14B |
| UnitedHealth Group | 279.09B |
| Abbott Laboratories | 233.16B |
| Novartis AG | 232.80B |
| AstraZeneca | 228.09B |